Our bodies are rich with self-healing stem cells that can be used to repair damaged tissues and control inflammation. By extracting stem cells from an area in your body where they are concentrated (fat tissue) and inserting them into the afflicted area, mesenchymal stem cell therapy is a safe and effective way to activate your body's build-in healing mechanisms. 

The following conditions have been found to have promising results using stem cell therapy:



Asthma is a chronic disease that causes the airway to become inflamed, resulting in chest tightness, shortness of breath, bronchospasm, coughing, wheezing, and airflow obstruction. There are many types of asthma, afflicting an estimated 300 million patients worldwide and responsible for hundreds of fatalities each year.

Asthma is usually treated with anticholinergics, beta 2 agonists, and corticosteroid inhalers. The anti-inflammatory properties of mesenchymal stem cells show promise in providing airway relief to patients suffering from various types of asthma. Candidacy must be evaluated on an individual basis.


COPD presents with poor airflow due to obstruction in the lungs over the long term, resulting in cough, sputum, and shortness of breath. Cigarette smoke is the most common cause, and symptoms tend to worsen over time.

Stem cell therapy has the potential to improve lung capacity and quality of life. Stem cells may have the ability to calm inflammation in the alveoli in the airway and slow the rate to lung cell death. New capillaries may even form, which could aid in oxygen delivery and tissue repair.


Congestive heart failure presents as an inability of the heart to pump enough blood to supply the body with sufficient oxygen. Symptoms include fatigue, labored breathing, and swollen legs. Symptoms can be debilitating and even fatal. Around 2% of adults in developed countries have heart failure, 6-10% in the 65+ age demographic.

Mesenchymal stem cells show promise in the treatment of heart failure in many ways, including the formation of new cardiac muscle tissue, new blood vessels and vessel tissue, and new smooth muscle tissue.


Diabetes mellitus refers to several related metabolic conditions that result in prolonged high blood sugar.  An estimated 415 million patients suffer from diabetes.  If untreated, life-threatening complications, including coma and ketoacidosis, can result.

In type 1 diabetes, the immune system attacks B-cells in the pancreas that produce insulin.  The immune-modulatory properties of mesenchymal stem cells could help mitigate this process.   Stem cells may also have the availability to differentiate into new B-cells, and as such have the potential to reverse the damage done by diabetes. 

Stem cell therapy has also demonstrated potential to reduce blood glucose levels in patients with type 2 diabetes.


Chronic kidney failure deprives the body of critical waste-filtration capacity.  The kidney could become severely impaired before any symptoms become evident, leading to a potentially fatal buildup of waste, fluids, and electrolytes in the body.

Kidney failure can often be trained to degeneration and loss of the epithelial cells that line the tubular nephrons within the kidney.  Mesenchymal stem cells may be able to differentiate into epithelial cells and heal the kidney from within.


Liver failure occurs when the liver is damaged beyond repair, and can threaten the patient’s life.  Initial symptoms are common to other conditions, making long-term liver deterioration difficult to diagnose.  Treatments usually focus on saving as much healthy liver tissue as possible. 

Stem cells injected into the bloodstream may have the ability to seek out areas of damage in the liver and differentiate into hepatocytes (liver cells) to repair and regenerate the liver, potentially negating the need for a liver transplant.